Back

RNA-based blood pressure lowering agents

2 September 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Novel drug therapies in hypertension: new kids on the block Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ernesto L Schiffrin

Jewish General Hospital, McGill University, Montreal (Canada)

4 More presentations in this session

Presentation thumbnail
Vaccines targeting the renin angiotensin system
Professor U. Kintscher (Berlin, DE)
Slides Video
Presentation thumbnail
Aldosterone synthase inhibition
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Dual endothelin receptor antagonist
Professor M. Tadic (Ulm, DE)
Slides Video
Presentation thumbnail
Novel drug therapies in hypertension: new kids on the block - discussion
Video

Access the full session

Session thumbnail
Novel drug therapies in hypertension: new kids on the block
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
RNA interference for treating hypertension
31 August 2024
thumbnail
Congress Presentation
Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial
30 August 2024
thumbnail
Congress Presentation
Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats
27 August 2023
thumbnail
Congress Presentation
State-of-the-art lecture on device-based hypertension management
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources